Hologic to provide tests for Scottish cervical screening programme

Hologic has entered into five-year managed service contracts for its ThinPrep Pap Test with eight health boards in Scotland.

The agreements will see the company's ThinPrep Pap Test and Imaging System utilised by cytology laboratories as part of the country's national cervical screening programme, which tests eligible women aged between 20 and 60 every three years.

Hologic's ThinPrep Pap Test is one of the most widely used methods for cervical cancer screening in the world and utilises a sampling device that is rinsed in a vial filled the proprietary PreservCyt solution, rather than being smeared on a microscope slide.

It means samples can be preserved before the cells can be damaged by air drying, while the ThinPrep Imaging System offers numerous benefits in terms of efficiency and accuracy.

Wayne Taylor, vice-president and general manager for Hologic in Europe, said: "Our ability to offer this technology in Scotland has taken cervical health screening to the next level, which we believe will be of benefit to all Scottish women."

Hologic is a leading women's health solutions provider that employs more than 6,000 people across North America, Europe, Central America, Australia and Asia.